The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Progression of Dysarthria and Dysphagia in Postmortem-Confirmed Parkinsonian Disorders
Abstract
BACKGROUND: Dysarthria and dysphagia are known to occur in parkinsonian syndromes such as Parkinson disease (PD), dementia with Lewy bodies (DLB), corticobasal degeneration (CBD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP). Differences in the evolution of these symptoms have not been studied systematically in postmortem-confirmed cases. OBJECTIVE: To study differences in the evolution of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. PATIENTS AND METHODS: Eighty-three pathologically confirmed cases (PD, n = 17; MSA, n = 15; DLB, n = 14; PSP, n = 24; and CBD, n = 13) formed the basis for a multicenter clinicopathological study organized by the National Institute of Neurological Disorders and Stroke, Bethesda, Md. Cases with enough clinicopathological documentation for the purpose of the study were selected from research and neuropathological files of 7 medical centers in 4 countries (Austria, France, England, and the United States). RESULTS: Median dysarthria latencies were short in PSP and MSA (24 months each), intermediate in CBD and DLB (40 and 42 months), and long in PD (84 months). Median dysphagia latencies were intermediate in PSP (42 months), DLB (43 months), CBD (64 months), and MSA (67 months), and long in PD (130 months). Dysarthria or dysphagia within 1 year of disease onset was a distinguishing feature for atypical parkinsonian disorders (APDs) (specificity, 100%) but failed to further distinguish among the APDs. Survival time after onset of a complaint of dysphagia was similar in PD, MSA, and PSP (15 to 24 months, P =.7) and latency to a complaint of dysphagia was highly correlated with total survival time (rho = 0.88; P<.001) in all disorders. CONCLUSIONS: Latency to onset of dysarthria and dysphagia clearly differentiated PD from the APDs, but did not help distinguish different APDs. Survival after onset of dysphagia was similarly poor among all parkinsonian disorders. Evaluation and adequate treatment of patients with PD who complain of dysphagia might prevent or delay complications such as aspiration pneumonia, which in turn may improve quality of life and increase survival time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Self-citationUnified Parkinson's Disease Rating Scale
(2012) · SpringerReference · doi:10.1007/springerreference_184495 · Cited by 3,066
Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.1 · Cited by 2,538 · cited 3×
“Analyses of covariance (general linear model) were performed to investigate the possible effects of (1) diagnosis, (2) age at onset, (3) severity of parkinsonism according to Hoehn and Yahr stages at the last clinic visit (median, 5 months before death), (4) presence of dementia according to Diagnostic and Statistical…”
MethodSelf-citationMembers of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale
Fahn, S. (1987) · Medical Entomology and Zoology · Cited by 2,163
STEELE, J. C. (1964) · Archives of Neurology · doi:10.1001/archneur.1964.00460160003001 · Cited by 1,924
Multiple system atrophy: A review of 203 pathologically proven cases
Wenning, G. K., Tison, F., ben Shlomo, Y., Daniel, S. E., & Quinn, N. P. (1997) · Movement Disorders · doi:10.1002/mds.870120203 · Cited by 803
Self-citationClinical features and natural history of multiple system atrophy: An analysis of 100 cases
Wenning, G. K., Shlomo, Y. B., Magalhães, M., Danie, S. E., & Quinn, N. P. (1994) · Brain · doi:10.1093/brain/117.4.835 · Cited by 788
Self-citationMultiple system atrophy--the nature of the beast.
Quinn, N. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.suppl.78 · Cited by 644
Cortical‐basal ganglionic degeneration
Riley, D. E., Lang, A. E., Lewis, A., Resch, L., Ashby, P., Hornykiewicz, O., & Black, S. (1990) · Neurology · doi:10.1212/wnl.40.8.1203 · Cited by 573
Cited by
Parkinson's disease: a dual‐hit hypothesis
Hawkes, C. H., Del Tredici, K., & Braak, H. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00874.x · Cited by 1,021
Gastrointestinal dysfunction in Parkinson's disease
Pfeiffer, R. F. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00307-7 · Cited by 925
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort
Williams-Gray, C. H., Mason, S. L., Evans, J. R., Foltynie, T., Brayne, C., Robbins, T. W., & Barker, R. A. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305277 · Cited by 681
ESPEN guideline clinical nutrition in neurology
Burgos, R., Bretón, I., Cereda, E., Desport, J. C., Dziewas, R., Genton, L., Gomes, F., Jésus, P., Leischker, A., Muscaritoli, M., et al. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2017.09.003 · Cited by 571
Prevalence of oropharyngeal dysphagia in Parkinson’s disease: A meta-analysis
Kalf, J. G., de Swart, B. J. M., Bloem, B. R., & Munneke, M. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.11.006 · Cited by 552
Wirth, R., Dziewas, R., Beck, A. M., Clave, P., Heppner, H. J., Langmore, S., Leischker, A., Martino, R., Pluschinski, P., Rösler, A., et al. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s97481 · Cited by 548
Dysphagia in Parkinson’s Disease
Suttrup, I., & Warnecke, T. (2016) · Dysphagia · doi:10.1007/s00455-015-9671-9 · Cited by 495
Ma, K., Xiong, N., Shen, Y., Han, C., Liu, L., Zhang, G., Wang, L., Guo, S., Guo, X., Xia, Y., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00001 · Cited by 379
Progression of Parkinson's disease in the clinical phase: potential markers
Maetzler, W., Liepelt, I., & Berg, D. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70291-1 · Cited by 305
Parkinson's Disease: The Dual Hit Theory Revisited
Hawkes, C. H., Del Tredici, K., & Braak, H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04365.x · Cited by 303
Gastrointestinal dysfunction in Parkinson's disease
Pfeiffer, R. F. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.08.003 · Cited by 298
The association of incident dementia with mortality in PD
Levy, G., Tang, M.-X., Louis, E. D., Côté, L. J., Alfaro, B., Mejia, H., Stern, Y., & Marder, K. (2002) · Neurology · doi:10.1212/01.wnl.0000036610.36834.e0 · Cited by 297
Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease
Jellinger, K. A., Seppi, K., Wenning, G. K., & Poewe, W. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200027 · Cited by 287
Self-citationPathological correlates of gastrointestinal dysfunction in Parkinson's disease
Cersosimo, M. G., & Benarroch, E. E. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.014 · Cited by 284
Seppi, K., Schocke, M. F. H., Esterhammer, R., Kremser, C., Brenneis, C., Mueller, J., Boesch, S., Jaschke, W., Poewe, W., & Wenning, G. K. (2003) · Neurology · doi:10.1212/01.wnl.0000049911.91657.9d · Cited by 256
Self-citationSpeech treatment in Parkinson's disease: Randomized controlled trial (RCT)
Ramig, L., Halpern, A., Spielman, J., Fox, C., & Freeman, K. (2018) · Movement Disorders · doi:10.1002/mds.27460 · Cited by 225
Fox, C., Ebersbach, G., Ramig, L., & Sapir, S. (2012) · Parkinson's Disease · doi:10.1155/2012/391946 · Cited by 178
“In contrast to previous medical “chart review” literature suggesting a mid- or late-stage onset of speech and swallowing symptoms in PD [22], more recent investigations with sensitive and valid measures consistently report speech symptoms in early PD (e.”
ResultRusz, J., Hlavnička, J., Tykalová, T., Bušková, J., Ulmanová, O., Růžička, E., & Šonka, K. (2016) · Sleep Medicine · doi:10.1016/j.sleep.2015.07.030 · Cited by 94
Gastrointestinal autonomic dysfunction in patients with Parkinson’s disease
Kim, J.-S., & Sung, H.-Y. (2015) · Journal of Movement Disorders · doi:10.14802/jmd.15008 · Cited by 76
Jones, C. A., Hoffman, M. R., Lin, L., Abdelhalim, S., Jiang, J. J., & McCulloch, T. M. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13236 · Cited by 35
Metadata
- Authors
- Müller, J., Wenning, G. K., Verny, M., McKee, A., Chaudhuri, K. R., Jellinger, K., Poewe, W., & Litvan, I.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2001-02-01
- Volume
- 58
- Issue
- 2
- Pages
- 259
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2105997121
- Cited by
- 414
- References
- 32
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.